Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The antimalarial ferroquine: from bench to clinic.

Identifieur interne : 000170 ( Hal/Checkpoint ); précédent : 000169; suivant : 000171

The antimalarial ferroquine: from bench to clinic.

Auteurs : Christophe Biot [France] ; F. Nosten [Royaume-Uni] ; L. Fraisse [France] ; D. Ter-Minassian [France] ; Jamal Khalife [France] ; Daniel Dive [France]

Source :

RBID : Hal:hal-00642112

Descripteurs français

English descriptors

Abstract

Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falciparum and P. vivax strains and/or isolates. This article focuses on the discovery of FQ, its antimalarial activity, the hypothesis of its mode of action, the current absence of resistance in vitro and recent clinical trials.


Url:
DOI: 10.1051/parasite/2011183207

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:hal-00642112

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The antimalarial ferroquine: from bench to clinic.</title>
<title xml:lang="fr">L’activité antipaludique de la ferroquine : de la recherche à la clinique</title>
<author>
<name sortKey="Biot, Christophe" sort="Biot, Christophe" uniqKey="Biot C" first="Christophe" last="Biot">Christophe Biot</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3209" status="VALID">
<idno type="IdRef">161608809</idno>
<idno type="ISNI">0000 0004 0368 3038</idno>
<idno type="RNSR">200612828X</idno>
<orgName>Unité de Catalyse et de Chimie du Solide - UMR 8181</orgName>
<orgName type="acronym">UCCS</orgName>
<desc>
<address>
<addrLine>Cité Scientifique - Bâtiment C3 59655 Villeneuve d'Ascq Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-56711" type="direct"></relation>
<relation active="#struct-120930" type="direct"></relation>
<relation active="#struct-300369" type="direct"></relation>
<relation active="#struct-374570" type="direct"></relation>
<relation name="UMR8181" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-56711" type="direct">
<org type="institution" xml:id="struct-56711" status="VALID">
<orgName>Université d'Artois</orgName>
<orgName type="acronym">UA</orgName>
<desc>
<address>
<addrLine>9 rue du Temple - BP 10665 - 62030 Arras cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-artois.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-120930" type="direct">
<org type="institution" xml:id="struct-120930" status="VALID">
<orgName>Ecole Centrale de Lille</orgName>
<desc>
<address>
<addrLine>Cité Scientifique - CS 20048 59651 Villeneuve d'Ascq Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ec-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300369" type="direct">
<org type="institution" xml:id="struct-300369" status="VALID">
<orgName>Ecole Nationale Supérieure de Chimie de Lille</orgName>
<orgName type="acronym">ENSCL</orgName>
<desc>
<address>
<addrLine>Cité ScientifiqueBât. C7Avenue MendeleïevCS 9010859652 VILLENEUVE D’ASCQ CEDEX</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ensc-lille.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8181" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Nosten, F" sort="Nosten, F" uniqKey="Nosten F" first="F." last="Nosten">F. Nosten</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-302612" status="VALID">
<orgName>University of Oxford [Oxford]</orgName>
<desc>
<address>
<addrLine>Wellington Square, Oxford OX1 2JD</addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ox.ac.uk/</ref>
</desc>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Fraisse, L" sort="Fraisse, L" uniqKey="Fraisse L" first="L." last="Fraisse">L. Fraisse</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-245586" status="INCOMING">
<orgName>Sanofi-Aventis [Toulouse]</orgName>
<desc>
<address>
<addrLine>195 Route d'Espagne, 31036 Toulouse</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300501" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300501" type="direct">
<org type="institution" xml:id="struct-300501" status="VALID">
<orgName>SANOFI Recherche</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Ter Minassian, D" sort="Ter Minassian, D" uniqKey="Ter Minassian D" first="D." last="Ter-Minassian">D. Ter-Minassian</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-467537" status="VALID">
<orgName>Sanofi Aventis R&D [Chilly-Mazarin]</orgName>
<desc>
<address>
<addrLine>1 Avenue Pierre Brossolette, 91380 Chilly-Mazarin</addrLine>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Khalife, Jamal" sort="Khalife, Jamal" uniqKey="Khalife J" first="Jamal" last="Khalife">Jamal Khalife</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-106189" status="VALID">
<idno type="IdRef">190712678</idno>
<idno type="ISNI">0000 0004 0386 3856</idno>
<idno type="RNSR">201019101Y</idno>
<orgName>Centre d’Infection et d’Immunité de Lille (CIIL) - U1019 - UMR 8204</orgName>
<orgName type="acronym">CIIL</orgName>
<date type="start">2010-01-01</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019 - BP 245</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ciil.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-301247" type="indirect"></relation>
<relation name="U1019" active="#struct-303623" type="direct"></relation>
<relation name="IFR142" active="#struct-374570" type="direct"></relation>
<relation name="UMR8204" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<date type="start">1894</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur-lille.fr/accueil/</ref>
</desc>
<listRelation>
<relation active="#struct-301247" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301247" type="indirect">
<org type="regroupinstitution" xml:id="struct-301247" status="VALID">
<orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc>
<address>
<addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1019" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="IFR142" active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8204" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dive, Daniel" sort="Dive, Daniel" uniqKey="Dive D" first="Daniel" last="Dive">Daniel Dive</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-106189" status="VALID">
<idno type="IdRef">190712678</idno>
<idno type="ISNI">0000 0004 0386 3856</idno>
<idno type="RNSR">201019101Y</idno>
<orgName>Centre d’Infection et d’Immunité de Lille (CIIL) - U1019 - UMR 8204</orgName>
<orgName type="acronym">CIIL</orgName>
<date type="start">2010-01-01</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019 - BP 245</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ciil.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-301247" type="indirect"></relation>
<relation name="U1019" active="#struct-303623" type="direct"></relation>
<relation name="IFR142" active="#struct-374570" type="direct"></relation>
<relation name="UMR8204" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<date type="start">1894</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur-lille.fr/accueil/</ref>
</desc>
<listRelation>
<relation active="#struct-301247" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301247" type="indirect">
<org type="regroupinstitution" xml:id="struct-301247" status="VALID">
<orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc>
<address>
<addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1019" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="IFR142" active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8204" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00642112</idno>
<idno type="halId">hal-00642112</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00642112</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-00642112</idno>
<idno type="doi">10.1051/parasite/2011183207</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Hal/Corpus">000237</idno>
<idno type="wicri:Area/Hal/Curation">000237</idno>
<idno type="wicri:Area/Hal/Checkpoint">000170</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000170</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The antimalarial ferroquine: from bench to clinic.</title>
<title xml:lang="fr">L’activité antipaludique de la ferroquine : de la recherche à la clinique</title>
<author>
<name sortKey="Biot, Christophe" sort="Biot, Christophe" uniqKey="Biot C" first="Christophe" last="Biot">Christophe Biot</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3209" status="VALID">
<idno type="IdRef">161608809</idno>
<idno type="ISNI">0000 0004 0368 3038</idno>
<idno type="RNSR">200612828X</idno>
<orgName>Unité de Catalyse et de Chimie du Solide - UMR 8181</orgName>
<orgName type="acronym">UCCS</orgName>
<desc>
<address>
<addrLine>Cité Scientifique - Bâtiment C3 59655 Villeneuve d'Ascq Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-56711" type="direct"></relation>
<relation active="#struct-120930" type="direct"></relation>
<relation active="#struct-300369" type="direct"></relation>
<relation active="#struct-374570" type="direct"></relation>
<relation name="UMR8181" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-56711" type="direct">
<org type="institution" xml:id="struct-56711" status="VALID">
<orgName>Université d'Artois</orgName>
<orgName type="acronym">UA</orgName>
<desc>
<address>
<addrLine>9 rue du Temple - BP 10665 - 62030 Arras cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-artois.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-120930" type="direct">
<org type="institution" xml:id="struct-120930" status="VALID">
<orgName>Ecole Centrale de Lille</orgName>
<desc>
<address>
<addrLine>Cité Scientifique - CS 20048 59651 Villeneuve d'Ascq Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ec-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300369" type="direct">
<org type="institution" xml:id="struct-300369" status="VALID">
<orgName>Ecole Nationale Supérieure de Chimie de Lille</orgName>
<orgName type="acronym">ENSCL</orgName>
<desc>
<address>
<addrLine>Cité ScientifiqueBât. C7Avenue MendeleïevCS 9010859652 VILLENEUVE D’ASCQ CEDEX</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ensc-lille.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8181" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Nosten, F" sort="Nosten, F" uniqKey="Nosten F" first="F." last="Nosten">F. Nosten</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-302612" status="VALID">
<orgName>University of Oxford [Oxford]</orgName>
<desc>
<address>
<addrLine>Wellington Square, Oxford OX1 2JD</addrLine>
<country key="GB"></country>
</address>
<ref type="url">http://www.ox.ac.uk/</ref>
</desc>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Fraisse, L" sort="Fraisse, L" uniqKey="Fraisse L" first="L." last="Fraisse">L. Fraisse</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-245586" status="INCOMING">
<orgName>Sanofi-Aventis [Toulouse]</orgName>
<desc>
<address>
<addrLine>195 Route d'Espagne, 31036 Toulouse</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300501" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300501" type="direct">
<org type="institution" xml:id="struct-300501" status="VALID">
<orgName>SANOFI Recherche</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Ter Minassian, D" sort="Ter Minassian, D" uniqKey="Ter Minassian D" first="D." last="Ter-Minassian">D. Ter-Minassian</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-467537" status="VALID">
<orgName>Sanofi Aventis R&D [Chilly-Mazarin]</orgName>
<desc>
<address>
<addrLine>1 Avenue Pierre Brossolette, 91380 Chilly-Mazarin</addrLine>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Khalife, Jamal" sort="Khalife, Jamal" uniqKey="Khalife J" first="Jamal" last="Khalife">Jamal Khalife</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-106189" status="VALID">
<idno type="IdRef">190712678</idno>
<idno type="ISNI">0000 0004 0386 3856</idno>
<idno type="RNSR">201019101Y</idno>
<orgName>Centre d’Infection et d’Immunité de Lille (CIIL) - U1019 - UMR 8204</orgName>
<orgName type="acronym">CIIL</orgName>
<date type="start">2010-01-01</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019 - BP 245</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ciil.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-301247" type="indirect"></relation>
<relation name="U1019" active="#struct-303623" type="direct"></relation>
<relation name="IFR142" active="#struct-374570" type="direct"></relation>
<relation name="UMR8204" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<date type="start">1894</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur-lille.fr/accueil/</ref>
</desc>
<listRelation>
<relation active="#struct-301247" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301247" type="indirect">
<org type="regroupinstitution" xml:id="struct-301247" status="VALID">
<orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc>
<address>
<addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1019" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="IFR142" active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8204" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dive, Daniel" sort="Dive, Daniel" uniqKey="Dive D" first="Daniel" last="Dive">Daniel Dive</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-106189" status="VALID">
<idno type="IdRef">190712678</idno>
<idno type="ISNI">0000 0004 0386 3856</idno>
<idno type="RNSR">201019101Y</idno>
<orgName>Centre d’Infection et d’Immunité de Lille (CIIL) - U1019 - UMR 8204</orgName>
<orgName type="acronym">CIIL</orgName>
<date type="start">2010-01-01</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019 - BP 245</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ciil.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-301247" type="indirect"></relation>
<relation name="U1019" active="#struct-303623" type="direct"></relation>
<relation name="IFR142" active="#struct-374570" type="direct"></relation>
<relation name="UMR8204" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<date type="start">1894</date>
<desc>
<address>
<addrLine>1 Rue du Professeur Calmette - Lille Cedex - 59019</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur-lille.fr/accueil/</ref>
</desc>
<listRelation>
<relation active="#struct-301247" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-301247" type="indirect">
<org type="regroupinstitution" xml:id="struct-301247" status="VALID">
<orgName>Réseau International des Instituts Pasteur</orgName>
<orgName type="acronym">RIIP</orgName>
<desc>
<address>
<addrLine>25, rue du Dr Roux 75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://research.pasteur.fr/ip-network</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1019" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="IFR142" active="#struct-374570" type="direct">
<org type="institution" xml:id="struct-374570" status="VALID">
<idno type="IdRef">223446556</idno>
<orgName>Université de Lille</orgName>
<date type="start">2018-01-01</date>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.univ-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR8204" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1051/parasite/2011183207</idno>
<series>
<title level="j">Parasite</title>
<idno type="ISSN">1252-607X</idno>
<imprint>
<date type="datePub">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>bioorganometallics</term>
<term>drug candidate</term>
<term>ferroquine</term>
<term>malaria</term>
<term>mechanism of action</term>
<term>resistance</term>
</keywords>
<keywords scheme="mix" xml:lang="fr">
<term>bio-organométallique</term>
<term>candidat médicament</term>
<term>ferroquine</term>
<term>mécanisme d’action</term>
<term>paludisme</term>
<term>résistance</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falciparum and P. vivax strains and/or isolates. This article focuses on the discovery of FQ, its antimalarial activity, the hypothesis of its mode of action, the current absence of resistance in vitro and recent clinical trials.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">The antimalarial ferroquine: from bench to clinic.</title>
<title xml:lang="fr">L’activité antipaludique de la ferroquine : de la recherche à la clinique</title>
<author role="crp">
<persName>
<forename type="first">Christophe</forename>
<surname>Biot</surname>
</persName>
<email type="md5">abe2ae0786be9d232a0f47c7ebc527ea</email>
<email type="domain">univ-lille1.fr</email>
<idno type="halauthorid">658980</idno>
<affiliation ref="#struct-3209"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">F.</forename>
<surname>Nosten</surname>
</persName>
<idno type="halauthorid">659641</idno>
<affiliation ref="#struct-302612"></affiliation>
<affiliation ref="#struct-560954"></affiliation>
<affiliation ref="#struct-202687"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">L.</forename>
<surname>Fraisse</surname>
</persName>
<idno type="halauthorid">55501</idno>
<affiliation ref="#struct-245586"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">D.</forename>
<surname>Ter-Minassian</surname>
</persName>
<idno type="halauthorid">659642</idno>
<affiliation ref="#struct-467537"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jamal</forename>
<surname>Khalife</surname>
</persName>
<email type="md5">167ebf82d12378fac020b67e81f6a6bf</email>
<email type="domain">pasteur-lille.fr</email>
<idno type="halauthorid">207769</idno>
<affiliation ref="#struct-106189"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Daniel</forename>
<surname>Dive</surname>
</persName>
<idno type="halauthorid">113560</idno>
<affiliation ref="#struct-106189"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Xavier</forename>
<surname>Trivelli</surname>
</persName>
<email type="md5">d10f7469116c076cad67315641c7b701</email>
<email type="domain">univ-lille1.fr</email>
</editor>
<funder>We acknowledge scientists who collaborated in the research: B. Pradines, T. Egan, K. Chibale, C. Slomianny, X. Trivelli, S. Bohic, E. Curis, and I. Forfar. F. Nosten is supported by the Wellcome Trust of Great Britain. We thank Ministère de l’Enseignement Supérieur, Université Lille Nord de France, CNRS and INSERM.</funder>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2019-09-16 11:52:36</date>
<date type="whenModified">2019-09-17 15:35:15</date>
<date type="whenReleased">2019-09-17 15:35:15</date>
<date type="whenProduced">2011</date>
<date type="whenEndEmbargoed">2019-09-16</date>
<ref type="file" target="https://hal.archives-ouvertes.fr/hal-00642112/document">
<date notBefore="2019-09-16"></date>
</ref>
<ref type="file" subtype="greenPublisher" n="1" target="https://hal.archives-ouvertes.fr/hal-00642112/file/Antimalarial_ferroquine_from_bench_to_clinic.pdf">
<date notBefore="2019-09-16"></date>
</ref>
<ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671469/pdf"></ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="156496">
<persName>
<forename>Xavier</forename>
<surname>Trivelli</surname>
</persName>
<email type="md5">d10f7469116c076cad67315641c7b701</email>
<email type="domain">univ-lille1.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-00642112</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00642112</idno>
<idno type="halBibtex">biot:hal-00642112</idno>
<idno type="halRefHtml">Parasite, EDP Sciences, 2011, 18 (3), pp.207-214. ⟨10.1051/parasite/2011183207⟩</idno>
<idno type="halRef">Parasite, EDP Sciences, 2011, 18 (3), pp.207-214. ⟨10.1051/parasite/2011183207⟩</idno>
<availability status="restricted">
<licence target="http://creativecommons.org/licenses/by/">Attribution</licence>
</availability>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="RIIP_LILLE">Institut Pasteur de Lille</idno>
<idno type="stamp" n="UNIV-ARTOIS">Université d'Artois</idno>
<idno type="stamp" n="RIIP">Institut Pasteur RIIP (Réseau International)</idno>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="EC-LILLE">Ecole Centrale de Lille</idno>
<idno type="stamp" n="ENSC-LILLE">Ecole Nationale Supérieure de Chimie de Lille</idno>
<idno type="stamp" n="UCCS">Unité de Catalyse et de Chimie du Solide</idno>
<idno type="stamp" n="INC-CNRS">Institut de Chimie du CNRS</idno>
<idno type="stamp" n="UNIV-LILLE">Université de Lille</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The antimalarial ferroquine: from bench to clinic.</title>
<title xml:lang="fr">L’activité antipaludique de la ferroquine : de la recherche à la clinique</title>
<author role="crp">
<persName>
<forename type="first">Christophe</forename>
<surname>Biot</surname>
</persName>
<email type="md5">abe2ae0786be9d232a0f47c7ebc527ea</email>
<email type="domain">univ-lille1.fr</email>
<idno type="halauthorid">658980</idno>
<affiliation ref="#struct-3209"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">F.</forename>
<surname>Nosten</surname>
</persName>
<idno type="halauthorid">659641</idno>
<affiliation ref="#struct-302612"></affiliation>
<affiliation ref="#struct-560954"></affiliation>
<affiliation ref="#struct-202687"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">L.</forename>
<surname>Fraisse</surname>
</persName>
<idno type="halauthorid">55501</idno>
<affiliation ref="#struct-245586"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">D.</forename>
<surname>Ter-Minassian</surname>
</persName>
<idno type="halauthorid">659642</idno>
<affiliation ref="#struct-467537"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jamal</forename>
<surname>Khalife</surname>
</persName>
<email type="md5">167ebf82d12378fac020b67e81f6a6bf</email>
<email type="domain">pasteur-lille.fr</email>
<idno type="halauthorid">207769</idno>
<affiliation ref="#struct-106189"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Daniel</forename>
<surname>Dive</surname>
</persName>
<idno type="halauthorid">113560</idno>
<affiliation ref="#struct-106189"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">21513</idno>
<idno type="issn">1252-607X</idno>
<idno type="eissn">1776-1042</idno>
<title level="j">Parasite</title>
<imprint>
<publisher>EDP Sciences</publisher>
<biblScope unit="volume">18</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="pp">207-214</biblScope>
<date type="datePub">2011</date>
</imprint>
</monogr>
<idno type="doi">10.1051/parasite/2011183207</idno>
<idno type="pubmed">21894260</idno>
<idno type="pubmedcentral">PMC3671469</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">resistance</term>
<term xml:lang="en">mechanism of action</term>
<term xml:lang="en">ferroquine</term>
<term xml:lang="en">drug candidate</term>
<term xml:lang="en">bioorganometallics</term>
<term xml:lang="en">malaria</term>
<term xml:lang="fr">résistance</term>
<term xml:lang="fr">mécanisme d’action</term>
<term xml:lang="fr">ferroquine</term>
<term xml:lang="fr">candidat médicament</term>
<term xml:lang="fr">bio-organométallique</term>
<term xml:lang="fr">paludisme</term>
</keywords>
<classCode scheme="mesh">Aminoquinolines/chemistry</classCode>
<classCode scheme="mesh">Aminoquinolines/pharmacology*</classCode>
<classCode scheme="mesh">Clinical Trials, Phase II as Topic</classCode>
<classCode scheme="mesh">Drug Resistance</classCode>
<classCode scheme="mesh">Ferrous Compounds/chemistry</classCode>
<classCode scheme="mesh">Ferrous Compounds/pharmacology*</classCode>
<classCode scheme="mesh">Ferrous Compounds/therapeutic use*</classCode>
<classCode scheme="mesh">Humans</classCode>
<classCode scheme="mesh">Malaria, Falciparum/drug therapy*</classCode>
<classCode scheme="mesh">Malaria, Vivax/drug therapy*</classCode>
<classCode scheme="mesh">Plasmodium falciparum/drug effects</classCode>
<classCode scheme="mesh">Plasmodium vivax/drug effects</classCode>
<classCode scheme="mesh">Aminoquinolines/therapeutic use*</classCode>
<classCode scheme="mesh">Animals</classCode>
<classCode scheme="mesh">Antimalarials/chemistry</classCode>
<classCode scheme="mesh">Antimalarials/pharmacology*</classCode>
<classCode scheme="mesh">Antimalarials/therapeutic use*</classCode>
<classCode scheme="mesh">Chloroquine/chemistry</classCode>
<classCode scheme="mesh">Chloroquine/pharmacology</classCode>
<classCode scheme="halDomain" n="sdv.bbm.bc">Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">
<p>Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falciparum and P. vivax strains and/or isolates. This article focuses on the discovery of FQ, its antimalarial activity, the hypothesis of its mode of action, the current absence of resistance in vitro and recent clinical trials.</p>
</abstract>
<abstract xml:lang="fr">
<p>La ferroquine (FQ, SSR97193) est actuellement le candidat médicament organométallique le plus avancé dans son développement industriel et, en tant que traitement du paludisme non compliqué, il devrait bientôt voir s’achever des études cliniques de phase II. Ce composé à base de ferrocène est extrêmement actif contre des isolats et/ou des clones de Plasmodium falciparum et de P. vivax sensibles ou résistants à la chloroquine. Cet article présente la découverte de la FQ, son activité antipaludique, les hypothèses liées à son mode d’action, l’absence actuelle de résistance in vitro et, enfin, les récents essais cliniques.</p>
</abstract>
<particDesc>
<org type="consortium">All searches on FQ carried out in laboratories * and ***** were funded by Pierre Fabre Médicament and Sanofi-Aventis. The two labs are very grateful to all Ph.D. students who participated to this work (L. Delhaës, H. Abessolo, W. Daher, N. Chavain, and F. Dubar) and provided an excellent work.</org>
</particDesc>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000170 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000170 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:hal-00642112
   |texte=   The antimalarial ferroquine: from bench to clinic.
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021